Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Morrison Briggs Create: Alert

All | News | Filings
Date FiledTypeDescription
04/13/2022 4/A Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Exercised 70,545 shares @ $7.2, valued at $507.9k
Exercised 3,128 shares @ $7.2, valued at $22.5k
Exercised 70,545 options to buy @ $0
Exercised 3,128 options to buy @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy